PUBLISHER: 360iResearch | PRODUCT CODE: 1595685
PUBLISHER: 360iResearch | PRODUCT CODE: 1595685
RSV Diagnostics Market by Product (Instruments, Kits & Assays), Methods (Molecular Diagnostics, Rapid Antigen Detection Tests), End-use - Global Forecast 2025-2030
The RSV Diagnostics Market was valued at USD 1.07 billion in 2023, expected to reach USD 1.17 billion in 2024, and is projected to grow at a CAGR of 9.20%, to USD 1.98 billion by 2030.
Respiratory Syncytial Virus (RSV) diagnostics are crucial in the healthcare landscape due to the virus's impact on infants, elderly, and immunocompromised individuals. The scope of RSV diagnostics encompasses diverse testing methodologies such as rapid antigen detection tests (RADTs), molecular diagnostics like RT-PCR, and serological assays. These play a pivotal role in early detection and management, thereby reducing the transmission and severity of RSV infections. The necessity of RSV diagnostics has surged, driven by increasing global awareness about viral infections and advancements in point-of-care testing technologies. End-use scopes primarily involve hospitals, diagnostic laboratories, and clinics, where efficient and quick decisions are vital for patient care. The market is poised for growth due to factors such as rising RSV prevalence, growing demand for decentralized diagnostic solutions, and advancements in healthcare infrastructure. However, challenges including high costs of advanced diagnostic tools, variability in test sensitivity, and regulatory hurdles can impede growth. Opportunities exist in the development of cost-effective, highly sensitive diagnostic alternatives and the integration of artificial intelligence to enhance accuracy and efficiency of RSV tests. Companies can capitalize on these opportunities by investing in technology-driven product development and expanding into high-growth emerging markets with burgeoning healthcare needs. Research and innovation can focus on enhancing molecular diagnostics, developing portable point-of-care devices, and exploring bioinformatics for predictive diagnostics. Despite the promising outlook, the market faces limitations such as competition from generic diagnostic methods, potential biosafety issues, and economic constraints in low-income regions. Strategic recommendations for businesses include forming partnerships with healthcare providers for broader product reach, focusing on R&D to drive innovation, and ensuring compliance with evolving regulations through strategic planning. The nature of the RSV diagnostics market is dynamic, with a trend towards personalized healthcare solutions, emphasizing the need for continual adaptation and innovation.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 1.07 billion |
| Estimated Year [2024] | USD 1.17 billion |
| Forecast Year [2030] | USD 1.98 billion |
| CAGR (%) | 9.20% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving RSV Diagnostics Market
The RSV Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Rising prevalence of respiratory infections among population
- Growing awareness about early diagnosis of infectious diseases
- Increasing approvals for syncytial virus diagnostic product
- Market Restraints
- Product recall issues associated with RSV diagnostic products
- Market Opportunities
- Advancements in respiratory syncytial virus diagnosis
- Growth in genomics and proteomics research
- Market Challenges
- Limitations associated with current RSV diagnostic products and procedures
Porter's Five Forces: A Strategic Tool for Navigating the RSV Diagnostics Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the RSV Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the RSV Diagnostics Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the RSV Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the RSV Diagnostics Market
A detailed market share analysis in the RSV Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the RSV Diagnostics Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the RSV Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the RSV Diagnostics Market
A strategic analysis of the RSV Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the RSV Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Altona Diagnostics GmbH, Atlas Medical GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, BTNX Inc., CerTest Biotec S.L., CTK Biotech, Inc., Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Hologic, Inc., Merck KGaA, Meridian Bioscience, Inc., Pro-Lab Diagnostics Inc., Qiagen GmbH, Quidel Corporation, SA Scientific, Ltd., Sansure Biotech Inc., Sentinel Ch S.p.A., Serion GmbH, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Vela Diagnostics Holding Pte Ltd., Virax Biolabs Group Limited, and Weldon Biotech, Inc..
Market Segmentation & Coverage
This research report categorizes the RSV Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Product, market is studied across Instruments and Kits & Assays.
- Based on Methods, market is studied across Molecular Diagnostics and Rapid Antigen Detection Tests.
- Based on End-use, market is studied across Home Care and Hospital & Clinics.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising prevalence of respiratory infections among population
- 5.1.1.2. Growing awareness about early diagnosis of infectious diseases
- 5.1.1.3. Increasing approvals for syncytial virus diagnostic product
- 5.1.2. Restraints
- 5.1.2.1. Product recall issues associated with RSV diagnostic products
- 5.1.3. Opportunities
- 5.1.3.1. Advancements in respiratory syncytial virus diagnosis
- 5.1.3.2. Growth in genomics and proteomics research
- 5.1.4. Challenges
- 5.1.4.1. Limitations associated with current RSV diagnostic products and procedures
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. RSV Diagnostics Market, by Product
- 6.1. Introduction
- 6.2. Instruments
- 6.3. Kits & Assays
7. RSV Diagnostics Market, by Methods
- 7.1. Introduction
- 7.2. Molecular Diagnostics
- 7.3. Rapid Antigen Detection Tests
8. RSV Diagnostics Market, by End-use
- 8.1. Introduction
- 8.2. Home Care
- 8.3. Hospital & Clinics
9. Americas RSV Diagnostics Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific RSV Diagnostics Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa RSV Diagnostics Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Abbott Laboratories
- 2. Altona Diagnostics GmbH
- 3. Atlas Medical GmbH
- 4. Becton, Dickinson and Company
- 5. Bio-Rad Laboratories, Inc.
- 6. bioMerieux SA
- 7. BTNX Inc.
- 8. CerTest Biotec S.L.
- 9. CTK Biotech, Inc.
- 10. Danaher Corporation
- 11. DiaSorin S.p.A.
- 12. F. Hoffmann-La Roche Ltd.
- 13. Hologic, Inc.
- 14. Merck KGaA
- 15. Meridian Bioscience, Inc.
- 16. Pro-Lab Diagnostics Inc.
- 17. Qiagen GmbH
- 18. Quidel Corporation
- 19. SA Scientific, Ltd.
- 20. Sansure Biotech Inc.
- 21. Sentinel Ch S.p.A.
- 22. Serion GmbH
- 23. Siemens Healthcare GmbH
- 24. Thermo Fisher Scientific Inc.
- 25. Vela Diagnostics Holding Pte Ltd.
- 26. Virax Biolabs Group Limited
- 27. Weldon Biotech, Inc.
LIST OF FIGURES
- FIGURE 1. RSV DIAGNOSTICS MARKET RESEARCH PROCESS
- FIGURE 2. RSV DIAGNOSTICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL RSV DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. RSV DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. RSV DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. RSV DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL RSV DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. RSV DIAGNOSTICS MARKET DYNAMICS
- TABLE 7. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY RAPID ANTIGEN DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 17. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 20. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 21. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 22. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 23. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 24. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 25. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 26. CANADA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 27. CANADA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 28. CANADA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 29. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 30. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 31. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 32. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 33. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 34. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 35. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 36. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 37. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 38. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 39. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 40. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 41. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 42. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 43. CHINA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 44. CHINA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 45. CHINA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 46. INDIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 47. INDIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 48. INDIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 49. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 50. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 51. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 52. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 53. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 54. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 55. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 56. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 57. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 58. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 59. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 60. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 61. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 62. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 63. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 64. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 65. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 66. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 67. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 68. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 69. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 70. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 71. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 72. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 73. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 74. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 75. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 76. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 77. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 78. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 79. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 80. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 81. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 82. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 83. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 84. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 85. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 86. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 87. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 88. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 89. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 90. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 91. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 92. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 93. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 94. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 95. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 96. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 97. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 98. ITALY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 99. ITALY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 100. ITALY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 101. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 102. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 103. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 104. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 105. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 106. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 107. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 108. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 109. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 110. POLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 111. POLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 112. POLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 113. QATAR RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 114. QATAR RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 115. QATAR RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 116. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 117. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 118. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 119. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 120. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 121. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 122. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 123. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 124. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 125. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 126. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 127. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 128. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 129. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 130. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 131. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 132. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 133. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 134. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 135. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 136. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 137. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 138. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 139. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 140. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 141. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
- TABLE 142. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 143. RSV DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 144. RSV DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
